Is Utah Medical Products, Inc. (UTMD) a Buy, Sell, or Hold?
NASDAQ : UTMD
Utah Medical Products, Inc. — News
$67.14 USD
$2.96 (4.61%)
- Volume
- 75.82K
- Average Volume
- 15.46K
- Market Capitalization
- $213.78M
- P/E Ratio
- 20.85
- Dividend Yield
- 1.84%
- Price Target
- Year High
- $75.75
- Year Low
- $53.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.38
- Current Ratio
- $48.62
| Source | Headline |
|---|---|
|
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026
SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same time periods in 2025. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. accessnewswire.com - 2026-07-23 09:00:00 |
|
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year. accessnewswire.com - 2026-05-05 10:00:00 |
|
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs
UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet. zacks.com - 2026-04-29 13:31:13 |
